ORCID verified
5 Aug 2026Open access
QSAR-Guided Virtual Screening and Molecular Dynamics Reveal Olaparib as a Repurposing Lead Against α-Synuclein AggregationPublisher siteInternational Journal of Molecular Sciences, Computational Drug Discovery Methods
Active, last published 2026
In computational drug discovery methods
Yassir
Boulaamane
Pioneer
Pathfinder
Scholar“Research focused on Computational Drug Discovery Methods and adjacent fields.”
9
H-index
216
Citations
This profile has been officially claimed and verified.
Honours
Pioneer
#1150
Pathfinder
EARNED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
assir Boulaamane is a researcher working on Computational Drug Discovery Methods. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Yassir's work has been cited 216 times across 5 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Computational Drug Discovery Methods×18Click Chemistry and Applications×4Cholinesterase and Neurodegenerative Diseases×4Parkinson's Disease Mechanisms and Treatments×2Protein Structure and Dynamics×2
04 · Where I am
Affiliations
Affiliation on published researchAbdelmalek Essaâdi University, MoroccoDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
22 works26 May 2026Open access
ARumenamides as Multitarget Ion Channel Modulators: Insights from Fenestration-Focused Docking, ADMET Profiling, and Molecular DynamicsPublisher siteInternational Journal of Molecular Sciences, Ion channel regulation and function
6 Apr 2026Open access
FDA-approved drug repurposing as p53 mutants rescue candidates using structure-based virtual screening and molecular simulationsPublisher siteResearch Square, Cancer-related Molecular Pathways
12 Mar 2026
Repurposing DrugBank compounds as NAD-dependent deacetylase sirtuin 2 inhibitors via QSAR modelling with gradient boosting algorithms and all-atom molecular simulationsPublisher siteMolecular Diversity, Sirtuins and Resveratrol in Medicine
24 Oct 2025Open access3cites
Drug Repurposing for AML: Structure-Based Virtual Screening and Molecular Simulations of FDA-Approved Compounds with Polypharmacological PotentialPublisher siteBiomedicines, Click Chemistry and Applications
29 Apr 2025Open access
Review of: "New Approach for Targeting Small Molecule Candidates for Intrinsically Disordered Proteins"Publisher site14 Apr 2025Open access8cites
Computational screening of natural products as tryptophan 2,3-dioxygenase inhibitors: Insights from CNN-based QSAR, molecular docking, ADMET, and molecular dynamics simulationsPublisher siteComputers in Biology and Medicine, Metabolomics and Mass Spectrometry Studies
5 Dec 20243cites
Metal and Metal Oxide Nanoparticles: Computational Analysis of Their Interactions and Antibacterial Activities Against Pseudomonas aeruginosaPublisher siteBioNanoScience, Nanoparticles: synthesis and applications
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Interested in this research?
MARATTO™ facilitates research-to-market partnerships between African universities and industry. Book a discovery call to explore collaboration with Yassir Boulaamane.